Santen has announced that the European Commission has granted market authorisation for Ryjunea, a low-dose atropine eye drop ...

Birmingham spin-out Linear Diagnostics has secured £1m funding to advance a rapid test for sexually transmitted infections ...

Sogroya acts as a replacement for endogenous growth hormone and is administered once a week to support growth in children ...

Flip feasibility: from capacity and capability to human realities True feasibility begins with understanding the patient.

Richard Condon, CEO Aspire Pharma, discusses successful leadership ...

The National Institute for Health and Care Excellence (NICE) has published updated guidance recommending Forxiga ...

The great NHS prescribing lottery. Imagine a patient in Manchester receiving a cutting-edge medication, while another in ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending mirikizumab (Omvoh) ...

As Europe’s adoption of the IDMP data model advances, EMA’s centralised Product Management Services (PMS) platform is coming ...

Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of non-opioid medicines ...

Over the past two decades, clinical trials have undergone significant transformation. Historically, trials followed a ...

The recent landmark ruling by the UK’s Supreme Court – that the term “sex” in the Equality Act 2010 refers to biological sex, ...